Mycobacterium abscessus strain variability in preclinical drug development: does it really matter? Mudde SE, Meliefste HM, Ammerman NC, de Steenwinkel JEM, et al. J Antimicrob Chemother 2024;79:3169-3173.

Read + Share

Amedeo Smart

Independent Medical Education

Mudde SE, Meliefste HM, Ammerman NC, de Steenwinkel JEM, et al. Mycobacterium abscessus strain variability in preclinical drug development: does it really matter? J Antimicrob Chemother 2024;79:3169-3173.
PMID: 39310935